Suppressive effect of low molecular weight fibrinogen degradation products on human and rat lymphocytes
- 1 March 1978
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 12 (3) , 523-530
- https://doi.org/10.1016/0049-3848(78)90323-7
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Chemotaxis for Human Monocytes by Fibrinogen‐derived PeptidesBritish Journal of Haematology, 1976
- Immunosuppression by micromolecular fibrinogen degradation products in cancerNature, 1976
- MOLECULAR STRUCTURAL STUDIES OF HUMAN FACTOR VIII*Annals of the New York Academy of Sciences, 1975
- Influence of Fibrinogen Degradation Products (FDP) on the Central Nervous System and on the Effects of Centrally Acting DrugsPharmacology, 1975
- 40. THE BIOLOGICAL AND PHARMACOLOGICAL PROPERTIES OF SOME FIBRINOGEN DEGRADATION PRODUCTS*Scandinavian Journal of Haematology, 1971
- Molecular weight analysis of oligopeptides by electrophoresis in polyacrylamide gel with sodium dodecyl sulfateAnalytical Biochemistry, 1971
- The pharmacological properties of fibrinogen degradation productsBritish Journal of Pharmacology, 1969
- THYMIDINE INCORPORATION IN MIXED CULTURES OF SPLEEN CELLS FROM MICE OF DIFFERING H-2 TYPESTransplantation, 1968
- A modified ninhydrin colorimetric analysis for amino acidsArchives of Biochemistry and Biophysics, 1957
- The purification of human fibrinogenBiochemical Journal, 1955